Results 141 to 150 of about 46,982 (194)

B7-H3-mediated cis-inhibition of EGFR by a tumor-selective bispecific antibody enhances anti-tumor efficacy and minimizes toxicities. [PDF]

open access: yesNat Commun
Guan J   +20 more
europepmc   +1 more source

CD86(B7-'2)antigen on B cells from atopic patients shows selective, antigen-specific upregulation

open access: yesCD86(B7-'2)antigen on B cells from atopic patients shows selective, antigen-specific upregulation
openaire  

Luteolin enhances antitumor immunity of B7-H3-targeted bispecific natural killer cell engagers against non-small cell lung cancer. [PDF]

open access: yesInt J Biol Sci
Yang S   +14 more
europepmc   +1 more source

Engineering T cell therapies for lung cancer. [PDF]

open access: yesMol Ther Oncol
Balke-Want H, Keerthi V, Feldman SA.
europepmc   +1 more source

Home - About - Disclaimer - Privacy